Evidence map›Paper›PMID 31574798›Full record

ArticleMedicine2019

Association between lymphocyte subsets and cytomegalovirus infection status among patients with systemic lupus erythematosus: A pilot study.

Ling Qin, Zhifeng Qiu, Evelyn Hsieh, Taoran Geng, Jiuliang Zhao, Xiaofeng Zeng, Lu Wan, Jing Xie, Rayoun Ramendra, Jean Pierre Routy and 1 more

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Potential Role of Upadacitinib in Cytomegalovirus Colitis Recurrence.European journal of case reports in internal medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. A Novel Scoring System for Prediction of Disease Severity in COVID-19.Frontiers in cellular and infection microbiology · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Ling QinDepartment of Infectious Diseases, Peking Union Medical College Hospital.
Zhifeng QiuDepartment of Infectious Diseases, Peking Union Medical College Hospital.
Evelyn HsiehDepartment of Infectious Diseases, Peking Union Medical College Hospital.
Taoran GengDepartment of Infectious Diseases, Peking Union Medical College Hospital.
Jiuliang ZhaoDepartment of Rheumatology.
Xiaofeng ZengDepartment of Rheumatology.
Lu WanDepartment of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Jing XieDepartment of Infectious Diseases, Peking Union Medical College Hospital.
Rayoun RamendraDepartment of Microbiology and Immunology, McGill University.
Jean Pierre RoutyChronic Viral Illnesses Service and Division of Hematology, McGill University Health Centre, Montreal, QC, Canada.
Taisheng LiDepartment of Infectious Diseases, Peking Union Medical College Hospital.
Johns Hopkins University Center for AIDS ResearchPeking Union Medical College Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNMcGill University · CAMcGill University Health Centre · CAYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Risk for Bone Loss Among Individuals with HIV in a Resource-Limited EnvironmentK01TW009995 · FIC · YALE UNIVERSITY · PI HSIEH, EVELYN · 2015 to 2019
$693k
FIC NIH HHS K01 TW009995NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

This study aimed to determine the association between different lymphocyte subsets and cytomegalovirus (CMV) infection status in patients with systemic lupus erythematosus (SLE). We performed a retrospective study among SLE patients with CMV infection and collected patient socio-demographic and clinical characteristics, as well as their recorded circulating lymphocyte subsets. Univariate and multivariable logistic regression analyses examined the relationship between CMV infection status and lymphocyte subset counts. We included 125 hospitalized patients with SLE, consisting of 88 with documented CMV infection and 37 without any evidence of CMV or other infections. Among the 88 CMV-infected patients, 65 (73.8%) patients developed CMV disease and 23 (26.2%) presented as CMV viremia. Compared to uninfected patients (1520 ± 101 cells/μL), lymphocytes remained stable among those with CMV viremia (1305 ± 272 cells/μL, P = .995). However, compared to their uninfected counterparts, there was a marked decrease in lymphocytes among patients with CMV disease (680 ± 513 cells/μL, P < .001). Analysis of lymphocyte subsets via flow cytometry showed that CD4+ T cell, CD8+ T cell, and natural killer cell counts were lower among those with CMV disease compared to those with CMV viremia and those without infection. Further, multivariable analysis showed that total lymphocyte (odds ratio [OR] 0.999, 95% confidence interval [CI] 0.998-1.000, P = .007) and CD4+ T cell counts (OR 0.99, 95% CI 0.992-0.998, P = .003) were negatively associated with CMV disease. Our findings support a potential inverse relationship between lymphopenia, specifically CD4+ T-cell lymphopenia, and CMV disease among hospitalized SLE patients.

Indexed as

Lymphocyte SubsetsAdultBlood SedimentationCase-Control StudiesCytomegalovirus InfectionsFemaleHumansLupus Erythematosus, SystemicLymphocyte CountLymphopeniaMalePilot ProjectsRetrospective StudiesViremia

Identifiers

PMID31574798
PMCPMC6775378
OpenAlexW2977075158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.